Design of a randomized controlled trial of smoking cessation medications for alcohol reduction among HIV-positive heavy drinkers and daily smokers in St. Petersburg, Russia

BACKGROUND: HIV, heavy drinking, and smoking are all pro-inflammatory and increase risk for coronary heart disease (CHD). Interventions that reduce alcohol use, smoking, or both in HIV-positive people could lower inflammation, CHD and death risk. Varenicline and cytisine are proven therapies for smo...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Contemp Clin Trials Commun
Main Authors: Tindle, Hilary A., Freiberg, Matthew S., Gnatienko, Natalia, Blokhina, Elena, Cheng, Debbie M., Yaroslavtseva, Tatiana, Bendiks, Sally, Winter, Michael, Krupitsky, Evgeny, Samet, Jeffrey H.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7889999/
https://ncbi.nlm.nih.gov/pubmed/33659761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.conctc.2020.100625
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki